PREVIOTOX

Serial Number 97882926
732

Registration Progress

Application Filed
Apr 11, 2023
Under Examination
Jul 16, 2024
Approved for Publication
May 21, 2024
Published for Opposition
May 21, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 16, 2026 192 days

Trademark Image

PREVIOTOX

Basic Information

Serial Number
97882926
Filing Date
April 11, 2023
Published for Opposition
May 21, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Dec 23, 2025
Application
Pending
Classes
005 010 042 044

Rights Holder

Mira DX, Inc.

03
Address
Suite 2410
11601 Wilshire Blvd.
Los Angeles, CA 90025

Ownership History

Mira DX, Inc.

Original Applicant
03
Los Angeles, CA

Mira DX, Inc.

Owner at Publication
03
Los Angeles, CA

Legal Representation

Attorney
Jessica L. Rothstein

USPTO Deadlines

Next Deadline
192 days remaining
NOA E-Mailed - SOU Required
Due Date
July 16, 2026
Extension Available
Until January 16, 2027

Application History

26 events
Date Code Type Description Documents
Dec 24, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 23, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 23, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 23, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 24, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 23, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 23, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 23, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 14, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 14, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 13, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 21, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 15, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 1, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 1, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 1, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 8, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 8, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 14, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs for medical purposes and also including collection tubes with caps, all with or without stabilizing reagents and with instructions, printed mailing labels and flat pack cardboard mailing boxes; DNA collection kit comprised of DNA collection laboratory swab and swab handle for medical purposes
Class 010
Anatomic pathology specimen collection kits for use in genetic testing comprised primarily of saliva and blood collection containers for medical purposes sold empty, printed instructions, printed shipping labels and transport packaging; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes
Class 042
Scientific research services, namely, DNA screening and genetic testing; medical research services, namely, DNA screening and genetic testing; Medical laboratory testing services; medical and scientific research in the field of genetics and DNA analysis; scientific research and development services relating to predicting toxicity in connection with immunotherapy treatments; research and development for the purpose of determining treatment selection in the field of immune oncology; providing scientific and medical research information in the field of genetics and DNA analysis
Class 044
Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity in connection with immunotherapy treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity in connection with immunotherapy treatments

Classification

International Classes
005 010 042 044